ID: ALA5177006

Max Phase: Preclinical

Molecular Formula: C38H59N11O10

Molecular Weight: 829.96

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C

Standard InChI:  InChI=1S/C38H59N11O10/c1-18(2)29(35(56)49-31(20(5)50)36(57)46-25(12-9-15-42-38(40)41)32(53)48-30(19(3)4)37(58)59)47-33(54)26(13-14-28(39)52)45-34(55)27(44-21(6)51)16-22-17-43-24-11-8-7-10-23(22)24/h7-8,10-11,17-20,25-27,29-31,43,50H,9,12-16H2,1-6H3,(H2,39,52)(H,44,51)(H,45,55)(H,46,57)(H,47,54)(H,48,53)(H,49,56)(H,58,59)(H4,40,41,42)/t20-,25+,26+,27+,29+,30+,31+/m1/s1

Standard InChI Key:  WSRPKCPSNWDWPM-WNYXTRFZSA-N

Associated Targets(Human)

Golgi-associated PDZ and coiled-coil motif-containing protein 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 829.96Molecular Weight (Monoisotopic): 829.4446AlogP: -2.05#Rotatable Bonds: 24
Polar Surface Area: 352.91Molecular Species: ZWITTERIONHBA: 10HBD: 13
#RO5 Violations: 2HBA (Lipinski): 21HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.78CX Basic pKa: 25.73CX LogP: -4.26CX LogD: -4.26
Aromatic Rings: 2Heavy Atoms: 59QED Weighted: 0.03Np Likeness Score: 0.16

References

1. Brusa I, Sondo E, Falchi F, Pedemonte N, Roberti M, Cavalli A..  (2022)  Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives.,  65  (7.0): [PMID:35377645] [10.1021/acs.jmedchem.1c01897]

Source